Novelos Therapeutics, Inc. , a pharmaceutical company developing novel drugs for the treatment and diagnosis of cancer, today announced that Harry Palmin, President and CEO of Novelos, will present a corporate update at the Benchmark 2012 Micro Cap Discovery Investor Conference on Thursday, November 29, 2012.
http://www.eteligis.com/ViewPressRelease.aspx?pressReleaseRequest=15963
http://www.eteligis.com/ViewPressRelease.aspx?pressReleaseRequest=15963
No comments:
Post a Comment